Dalbir S. Sandhu

Sulfatase 2 up‐regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma†

Jinping Lai, Dalbir S. Sandhu, Chunrong Yu et al. · Hepatology · 2008 · 206 citations · Full text

Medicine, Molecular Biology, Oncology +17

Impact of COVID-19 on endoscopy trainees: an international survey

Katarzyna M. Pawlak, Jan Král, Rishad Khan et al. · Gastrointestinal Endoscopy · 2020 · 108 citations · Full text

Medicine, Infectious Diseases, Medical Education +10

Colorectal Cancer, Age, and Obesity-Related Comorbidities: A Large Database Study

Abbinaya Elangovan, Jacob Skeans, Marc Landsman et al. · Digestive Diseases and Sciences · 2020 · 75 citations

Medicine, Biostatistics, Oncology +16

Heparin-Degrading Sulfatases in Hepatocellular Carcinoma: Roles in Pathogenesis and Therapy Targets

Jin-Ping Lai, James Thompson, Dalbir S. Sandhu et al. · Future Oncology · 2008 · 54 citations · Full text

Medicine, Cancer Biology, Oncology +17

Viral Hepatitis Among Somali Immigrants in Minnesota: Association of Hepatitis C With Hepatocellular Carcinoma

Abdirashid M. Shire, Dalbir S. Sandhu, Joseph Kaiya et al. · Mayo Clinic Proceedings · 2012 · 39 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +16